Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Axatilimab-csfr Injection

Brand Name(s): Niktimvo®

WHY is this medicine prescribed?

Axatilimab-csfr injection is used to treat graft versus host disease (GVHD; a condition in which the immune system begins attacking newly transplanted organs, stem cells or bone marrow) in adults and some children who have not responded to two other therapies. Axatilimab-csfr is in a class of medications called monoclonal antibodies. It works by stopping the immune system from attacking the newly transplanted tissue, cells, or bone marrow.

Are there OTHER USES for this medicine?

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

HOW should this medicine be used?

Axatilimab-csfr comes as a solution (liquid) to be given intravenously (into the vein) by a doctor or nurse at a hospital or clinic. It is usually given over 30 minutes every 2 weeks.Your doctor will decide how long you should receive axatilimab-csfr.

Your doctor will draw labs to check for side effects axatilimab-csfr. Your doctor may adjust your dose or interrupt your therapy based on these results. Your doctor may give you other medications before receiving axatilimab-csfr to prevent infusion-related side effects (fever, chills, rash, flushing, difficulty breathing). It is important that you tell your doctor or nurse how you feel during treatment.

What SPECIAL PRECAUTIONS should I follow?

Before receiving axatilimab-csfr injection,

  • tell your doctor and pharmacist if you are allergic to axatilimab-csfr, any other medications, or any of the ingredients in axatilimab-csfr injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.

  • tell your doctor if you have or have ever had liver problems.

  • tell your doctor if you are pregnant or plan to become pregnant. If you are female, you will need to have a pregnancy test before you start treatment, and you should use birth control to prevent pregnancy during your axatilimab-csfr treatment and for 30 days after your final dose. Talk to your doctor about birth control methods that you can use during your treatment. If you or your partner become pregnant while taking axatilimab-csfr, call your doctor.Axatilimab-csfr may harm the fetus.

  • tell your doctor if you are breastfeeding. You should not breastfeed during your treatment with axatilimab-csfr and for at least 30 days after your final dose.

  • do not have any vaccinations without talking to your doctor.

What SPECIAL DIETARY instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What SIDE EFFECTS can this medicine cause?

Axatilimab-csfr may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • muscle, bone or joint pain
  • low energy
  • nausea
  • headache
  • diarrhea

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

  • fever, cough, shortness of breath
  • lower abdominal pain, yellowing of skin or whites of eyes, dark urine
  • severe upper abdominal pain, tenderness in the upper abdomen, fever
  • fever, difficulty or painful urination or frequent urination, lower back pain
  • low energy, pale skin, chest pain, shortness of breath

Axatilimab-csfr may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (https://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to axatilimab-csfr.

If you miss an appointment to receive your dose, call your doctor right away.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary